Clementia Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Clementia Pharmaceuticals's estimated annual revenue is currently $8M per year. 0
- Clementia Pharmaceuticals's total funding is $92.5M.
Employee Data
- 00
Clementia Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer, Clementia Pharmaceuticals | Reveal Email/Phone |
2 | Spécialiste Assurance Qualité | Reveal Email/Phone |
Clementia Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Clementia Pharmaceuticals?
Clementia is a privately held clinical stage biopharmaceutical company dedicated to the development and commercialization of treatments for people living with rare diseases by exploiting the science of novel retinoic acid receptor gamma agonists to address bone diseases, including Fibrodysplasia Ossificans Progressiva (FOP).
keywords:N/A
$92.5M
Total Funding
N/A
Number of Employees
$8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clementia Pharmaceuticals News
Boehringer Ingelheim Gmbh; Clementia Pharmaceuticals Inc; Galderma Sa; Lee's Pharmaceutical Holdings Ltd; Phosphagenics Ltd; Promius Pharma Llc; Sol-gel...
... Limited, Regeneron Pharmaceuticals, Inc, Clementia Pharmaceuticals, ... La Jolla Pharmaceutical Company, Biocryst Pharmaceuticals, Inc.,...
Fibrodysplasia Ossificans Progressiva Drug Market Report by Material, Application, and Geography – Global Forecast to 2024 is a professional and in-depth ...
Investors are keeping a close eye on shares of Clementia Pharmaceuticals Inc. (CMTA). The stock has a current six month price index of ...
Ipsen (Euronext: IPN; ADR: IPSEY) and Clementia Pharmaceuticals (NASDAQ: CMTA) today announced the closing of Ipsen's acquisition of ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 0 | N/A | $23M |
#2 | $20.4M | 0 | N/A | N/A |
#3 | $15M | 0 | N/A | N/A |
#4 | N/A | 0 | N/A | $10.9M |
#5 | $17.4M | 0 | N/A | $0.15M |